Blood lipids often shift across the menopausal transition. But the most interesting question is not simply whether cholesterol rises. It is why different lipid traits behave so differently between women.
A large female twin study measured total cholesterol, LDL, HDL, triglycerides, ApoA1, ApoB and Lp(a), then asked how genetic and environmental contributions differed before and after menopause.
Quick answer
Does menopause change the genetic influence on blood lipids?
For several lipid and apolipoprotein traits, the study found differences in the balance of genetic and shared-environment contributions before and after menopause. Lp(a) was the standout exception: it showed very high heritability, about 87%, with a similar model across menopausal groups.
Key takeaways
- The study included 453 monozygotic and 1,280 dizygotic female twin pairs.
- Researchers measured total cholesterol, LDL, HDL, triglycerides, ApoA1, ApoB and Lp(a).
- Lp(a) showed an estimated heritability around 87% in this cohort.
- For several other lipid traits, shared-environment contributions seen before menopause became smaller or disappeared after menopause.
- LDL, ApoB, triglycerides, HDL and Lp(a) should not be treated as interchangeable versions of the same “cholesterol gene”.
Menopause changes physiology — and lipid patterns
The menopausal transition involves major hormonal changes, especially declining ovarian estrogen. Average lipid profiles can shift during this period, but averages hide large individual differences.
Twin research is useful because it can ask whether the source of that variation also changes: are women differing mainly because of inherited factors, shared family environment, or experiences unique to each twin?
One study, seven lipid-related traits
Researchers studied 453 monozygotic and 1,280 dizygotic female twin pairs from the St Thomas’ UK Adult Twin Registry.
They measured total cholesterol, LDL, HDL, triglycerides, Lp(a), ApoA1 and ApoB. These markers overlap biologically, but they describe different particles or functions — and their genetic architecture is not identical.
Lp(a) was the genetic standout
Lp(a) showed an estimated heritability of approximately 87%, with the same broad model fitting women before and after menopause.
That high inherited component is consistent with modern evidence that Lp(a) concentration is strongly genetically determined. It does not mean environment and overall cardiovascular risk are irrelevant; it means this particular biomarker behaves differently from many routine lipid measures.
For other lipids, the balance shifted
Before menopause, shared environmental factors contributed to variation in several lipid and apolipoprotein traits. After menopause, those shared-environment estimates were reduced or absent for several measures in the model.
This does not mean menopause “turns on bad genes”. It suggests that the relative sources of between-person variation can change when the hormonal environment changes.
TwinPare perspective: one blood panel contains many biological stories
It is tempting to talk about “cholesterol” as one thing. The twin evidence argues for a more precise vocabulary.
Lp(a), LDL-C, ApoB, triglycerides, HDL-C and ApoA1 describe different aspects of lipid transport and risk. Their levels can be differently influenced by genetics, hormones, diet, medication and metabolism. Precision begins by not treating them as synonyms.
Source notes
The sources have been verified and editorially reviewed for this article. The limitations below show which level of conclusion the sources support.
- [middelberg-2002] Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause Rita P S Middelberg et al.. Arteriosclerosis, Thrombosis, and Vascular Biology, 2002. Evidence type: Large female twin study (453 monozygotic and 1,280 dizygotic pairs) Limitation: Lp(a) showed very high heritability in this cohort, while genetic/shared-environment contributions for other lipid traits differed before and after menopause. This does not make any single lipid value immutable. PubMed DOI
- [kronenberg-2022] Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement Florian Kronenberg et al.. European Heart Journal, 2022. Evidence type: European Atherosclerosis Society consensus statement integrating epidemiology and genetics Limitation: Lp(a) is strongly genetically determined and causally linked to ASCVD in converging evidence. Clinical testing and treatment decisions remain matters for qualified care. PubMed DOI
Editorial source review
This section shows how the article's key factual claims are linked to the source.
Phrasings that require caution
- Do not interpret high heritability of Lp(a) as a fixed individual cardiovascular outcome.
- Do not imply menopause alone causes cardiovascular disease.
- Laboratory values require clinical interpretation in the context of overall risk.
| ID | Claim | Source support | Caution |
|---|